NEFL and Brain atrophy: Higher concentrations of serum NfL reflect disease severity, as they are associated with faster rates of brain atrophy, and baseline NfL was significantly elevated in subjects who converted from presymptomatic to symptomatic or showed disease progression versus non-progressors.